Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ITUB✓SelectedUSD · ITUBGSK vs ITUB performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs ITUB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
ITUB return
+49.4%
Excess return
+3.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioITUBExcessAlpha
1D-0.1%-2.5%+2.4%+0.1%
7D-5.3%-13.4%+8.1%-3.9%
30D-3.7%-32.8%+29.1%-0.1%
3M-7.3%-9.0%+1.7%-8.2%
6M-4.2%-16.9%+12.7%-4.0%
YTD+0.9%-6.9%+7.8%-0.7%
1Y+7.3%-1.2%+8.5%+4.6%
3Y+52.7%+47.3%+5.4%+39.8%
All+52.7%+49.4%+3.3%+39.8%

Cumulative growth

Daily Returns

Daily percentage return beside ITUB.

Daily Out/Under-Performance

Portfolio return minus ITUB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ITUB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ITUB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling